Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Non Operating Income: 2017-2024

Historic Non Operating Income for Solid Biosciences (SLDB) over the last 7 years, with Dec 2024 value amounting to -$2.7 million.

  • Solid Biosciences' Non Operating Income fell 240.02% to -$2.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year decrease of 38.92%. This contributed to the annual value of $5.0 million for FY2024, which is 38.92% down from last year.
  • As of Q4 2024, Solid Biosciences' Non Operating Income stood at -$2.7 million, which was down 209.93% from $2.5 million recorded in Q3 2024.
  • In the past 5 years, Solid Biosciences' Non Operating Income ranged from a high of $19.4 million in Q4 2022 and a low of -$2.7 million during Q4 2024.
  • In the last 3 years, Solid Biosciences' Non Operating Income had a median value of $2.1 million in 2023 and averaged $3.0 million.
  • As far as peak fluctuations go, Solid Biosciences' Non Operating Income surged by 4,931.82% in 2023, and later plummeted by 240.02% in 2024.
  • Over the past 4 years, Solid Biosciences' Non Operating Income (Quarterly) stood at -$16,000 in 2020, then reached $19.4 million in 2022, then crashed by 90.06% to $1.9 million in 2023, then crashed by 240.02% to -$2.7 million in 2024.
  • Its Non Operating Income stands at -$2.7 million for Q4 2024, versus $2.5 million for Q3 2024 and $2.7 million for Q2 2024.